The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ajuebor, M. N.
Right arrow Articles by Swain, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ajuebor, M. N.
Right arrow Articles by Swain, M. G.
The Journal of Immunology, 2003, 170: 5252-5259.
Copyright © 2003 by The American Association of Immunologists

C-C Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Directly Inhibits NKT Cell IL-4 Production and Is Hepatoprotective in T Cell-Mediated Hepatitis in the Mouse1

Maureen N. Ajuebor*, Cory M. Hogaboam{dagger}, Tai Le* and Mark G. Swain2,*

* Liver Unit, Gastrointestinal Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; {dagger} Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109

T cell-mediated liver diseases are associated with elevated serum levels of C-C chemokine ligand 2 (CCL2)/monocyte chemoattractant protein-1 (MCP-1). However, the extent to which the actions of CCL2/MCP-1 contribute to the pathogenesis of T cell-mediated hepatitis remains incompletely understood. Con A-induced hepatitis is a liver-specific inflammation mediated by activated T cells and is driven by an up-regulation of the hepatic expression of TNF-{alpha}, IFN-{gamma}, and IL-4. The present study examined the role of CCL2/MCP-1 in the pathogenesis of T cell-mediated hepatitis induced by Con A administration in the mouse. We demonstrate a novel hepatoprotective role for CCL2/MCP-1 during Con A-induced hepatitis, because CCL2/MCP-1 neutralization strikingly enhanced hepatic injury, both biochemically and histologically, after Con A administration. Furthermore, CCL2/MCP-1 neutralization was associated with a significant reduction in the hepatic levels of TNF-{alpha} and IFN-{gamma}, but with a significant increase in hepatic IL-4 levels. Moreover, IL-4 production and CCR2 expression by Con A-stimulated CD3+NK1.1+ T cells was significantly reduced by rMCP-1 treatment in vitro. In summary, we propose that CCL2/MCP-1 fulfills a novel anti-inflammatory role in T cell-mediated hepatitis by inhibiting CD3+NK1.1+ T cell-derived IL-4 production through direct stimulation of its specific receptor CCR2. These findings may have direct clinical relevance to T cell-mediated hepatitis.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. N. Ajuebor, Y. Jin, G. L. Gremillion, R. M. Strieter, Q. Chen, and P. A. Adegboyega
{gamma}{delta}T Cells Initiate Acute Inflammation and Injury in Adenovirus-Infected Liver via Cytokine-Chemokine Cross Talk
J. Virol., October 1, 2008; 82(19): 9564 - 9576.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D H Adams, B Eksteen, and S M Curbishley
Immunology of the gut and liver: a love/hate relationship
Gut, June 1, 2008; 57(6): 838 - 848.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. N. Ajuebor, Z. Wondimu, C. M. Hogaboam, T. Le, A. E.I. Proudfoot, and M. G. Swain
CCR5 Deficiency Drives Enhanced Natural Killer Cell Trafficking to and Activation within the Liver in Murine T Cell-Mediated Hepatitis
Am. J. Pathol., June 1, 2007; 170(6): 1975 - 1988.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Bursill, J. L. Cash, K. M. Channon, and D. R. Greaves
Membrane-Bound CC Chemokine Inhibitor 35K Provides Localized Inhibition of CC Chemokine Activity In Vitro and In Vivo
J. Immunol., October 15, 2006; 177(8): 5567 - 5573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. N. Ajuebor, J. A. Carey, and M. G. Swain
CCR5 in T Cell-Mediated Liver Diseases: What's Going On?
J. Immunol., August 15, 2006; 177(4): 2039 - 2045.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kawamura, F. Aswad, M. Minagawa, S. Govindarajan, and G. Dennert
P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis
J. Immunol., February 15, 2006; 176(4): 2152 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. N. Ajuebor, A. I. Aspinall, F. Zhou, T. Le, Y. Yang, S. J. Urbanski, S. Sidobre, M. Kronenberg, C. M. Hogaboam, and M. G. Swain
Lack of Chemokine Receptor CCR5 Promotes Murine Fulminant Liver Failure by Preventing the Apoptosis of Activated CD1d-Restricted NKT Cells
J. Immunol., June 15, 2005; 174(12): 8027 - 8037.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. S. Bonder, M. N. Ajuebor, L. D. Zbytnuik, P. Kubes, and M. G. Swain
Essential Role for Neutrophil Recruitment to the Liver in Concanavalin A-Induced Hepatitis
J. Immunol., January 1, 2004; 172(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y.-W. Chen, M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson
Molecular responses of human muscle to eccentric exercise
J Appl Physiol, December 1, 2003; 95(6): 2485 - 2494.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.